Ultragenyx Pharma (RARE) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 15.95 +0.03 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.92 | 52 Week High | $117.12 | |||
| Open | $15.78 | 52 Week Low | $46.52 | |||
| Day High | $16.25 | P/E | N/A | |||
| Day Low | $15.60 | EPS | $-1.97 | |||
| Volume | 2,374,267 | |||||
